dr. blackwell discusses the her2climb study in her2 breast cancer
Published 6 years ago • 283 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
2:36
dr. blackwell discusses tucatinib in her2 breast cancer
-
1:15
dr. blackwell on the impact of the cleopatra and marianne studies in her2 breast cancer
-
1:39
dr. blackwell on treatment landscape of her2 breast cancer
-
1:44
dr. blackwell on neratinib in her2 breast cancer
-
1:00
dr. blackwell discusses margetuximab for her2 breast cancer
-
1:40
her2climb study shows efficacy in her2 breast cancer with brain metastases
-
0:46
dr. kimberly l. blackwell on a promising her2 breast cancer treatment
-
3:35
understanding the her2climb trial
-
1:50
dr. kimberly blackwell discusses the t-dm1 emilia trial
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
0:59
dr. linda vahdat on frontline eribulin plus trastuzumab in her2-positive mbc
-
3:08
the benefits of tucatinib in her2 breast cancer
-
1:42
dr. hamilton on the her2climb trial in metastatic her2 breast cancer
-
1:04
dr. kimberly blackwell discusses the t-dm1 emilia trial coprimary endpoints
-
1:56
dr. rimawi discusses katherine trial in her2 breast cancer
-
0:51
dr. jhaveri on the use of trastuzumab biosimilars in breast cancer
-
0:52
dr. blackwell on emerging therapies in tnbc
-
2:35
dr. rugo on the phase iii sophia trial in her2 breast cancer